EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $499,000 | +43.4% | 6,600 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $348,000 | -1.4% | 6,600 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $353,000 | -10.4% | 6,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $394,000 | -24.4% | 6,600 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $521,000 | -53.6% | 6,600 | -56.4% | 0.01% | -73.9% |
| Q3 2015 | $1,122,000 | -56.8% | 15,150 | -52.8% | 0.02% | -54.9% |
| Q2 2015 | $2,597,000 | +94.0% | 32,118 | +0.5% | 0.05% | +82.1% |
| Q1 2015 | $1,339,000 | +170.0% | 31,968 | 0.0% | 0.03% | +154.5% |
| Q4 2014 | $496,000 | +130.7% | 31,968 | +88.4% | 0.01% | +120.0% |
| Q3 2014 | $215,000 | – | 16,968 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |